A high-throughput screen for tuberculosis progression.

One-third of the world population is infected with Mycobacterium tuberculosis and multi-drug resistant strains are rapidly evolving. The noticeable absence of a whole organism high-throughput screening system for studying the progression of tuberculosis is fast becoming the bottleneck in tuberculosi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ralph Carvalho, Jan de Sonneville, Oliver W Stockhammer, Nigel D L Savage, Wouter J Veneman, Tom H M Ottenhoff, Ron P Dirks, Annemarie H Meijer, Herman P Spaink
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f48d3188535341409455dd502ae3be14
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f48d3188535341409455dd502ae3be14
record_format dspace
spelling oai:doaj.org-article:f48d3188535341409455dd502ae3be142021-11-18T06:58:39ZA high-throughput screen for tuberculosis progression.1932-620310.1371/journal.pone.0016779https://doaj.org/article/f48d3188535341409455dd502ae3be142011-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21390204/?tool=EBIhttps://doaj.org/toc/1932-6203One-third of the world population is infected with Mycobacterium tuberculosis and multi-drug resistant strains are rapidly evolving. The noticeable absence of a whole organism high-throughput screening system for studying the progression of tuberculosis is fast becoming the bottleneck in tuberculosis research. We successfully developed such a system using the zebrafish Mycobacterium marinum infection model, which is a well-characterized model for tuberculosis progression with biomedical significance, mimicking hallmarks of human tuberculosis pathology. Importantly, we demonstrate the suitability of our system to directly study M. tuberculosis, showing for the first time that the human pathogen can propagate in this vertebrate model, resulting in similar early disease symptoms to those observed upon M. marinum infection. Our system is capable of screening for disease progression via robotic yolk injection of early embryos and visual flow screening of late-stage larvae. We also show that this system can reliably recapitulate the standard caudal vein injection method with a throughput level of 2,000 embryos per hour. We additionally demonstrate the possibility of studying signal transduction leading to disease progression using reverse genetics at high-throughput levels. Importantly, we use reference compounds to validate our system in the testing of molecules that prevent tuberculosis progression, making it highly suited for investigating novel anti-tuberculosis compounds in vivo.Ralph CarvalhoJan de SonnevilleOliver W StockhammerNigel D L SavageWouter J VenemanTom H M OttenhoffRon P DirksAnnemarie H MeijerHerman P SpainkPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 2, p e16779 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ralph Carvalho
Jan de Sonneville
Oliver W Stockhammer
Nigel D L Savage
Wouter J Veneman
Tom H M Ottenhoff
Ron P Dirks
Annemarie H Meijer
Herman P Spaink
A high-throughput screen for tuberculosis progression.
description One-third of the world population is infected with Mycobacterium tuberculosis and multi-drug resistant strains are rapidly evolving. The noticeable absence of a whole organism high-throughput screening system for studying the progression of tuberculosis is fast becoming the bottleneck in tuberculosis research. We successfully developed such a system using the zebrafish Mycobacterium marinum infection model, which is a well-characterized model for tuberculosis progression with biomedical significance, mimicking hallmarks of human tuberculosis pathology. Importantly, we demonstrate the suitability of our system to directly study M. tuberculosis, showing for the first time that the human pathogen can propagate in this vertebrate model, resulting in similar early disease symptoms to those observed upon M. marinum infection. Our system is capable of screening for disease progression via robotic yolk injection of early embryos and visual flow screening of late-stage larvae. We also show that this system can reliably recapitulate the standard caudal vein injection method with a throughput level of 2,000 embryos per hour. We additionally demonstrate the possibility of studying signal transduction leading to disease progression using reverse genetics at high-throughput levels. Importantly, we use reference compounds to validate our system in the testing of molecules that prevent tuberculosis progression, making it highly suited for investigating novel anti-tuberculosis compounds in vivo.
format article
author Ralph Carvalho
Jan de Sonneville
Oliver W Stockhammer
Nigel D L Savage
Wouter J Veneman
Tom H M Ottenhoff
Ron P Dirks
Annemarie H Meijer
Herman P Spaink
author_facet Ralph Carvalho
Jan de Sonneville
Oliver W Stockhammer
Nigel D L Savage
Wouter J Veneman
Tom H M Ottenhoff
Ron P Dirks
Annemarie H Meijer
Herman P Spaink
author_sort Ralph Carvalho
title A high-throughput screen for tuberculosis progression.
title_short A high-throughput screen for tuberculosis progression.
title_full A high-throughput screen for tuberculosis progression.
title_fullStr A high-throughput screen for tuberculosis progression.
title_full_unstemmed A high-throughput screen for tuberculosis progression.
title_sort high-throughput screen for tuberculosis progression.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/f48d3188535341409455dd502ae3be14
work_keys_str_mv AT ralphcarvalho ahighthroughputscreenfortuberculosisprogression
AT jandesonneville ahighthroughputscreenfortuberculosisprogression
AT oliverwstockhammer ahighthroughputscreenfortuberculosisprogression
AT nigeldlsavage ahighthroughputscreenfortuberculosisprogression
AT wouterjveneman ahighthroughputscreenfortuberculosisprogression
AT tomhmottenhoff ahighthroughputscreenfortuberculosisprogression
AT ronpdirks ahighthroughputscreenfortuberculosisprogression
AT annemariehmeijer ahighthroughputscreenfortuberculosisprogression
AT hermanpspaink ahighthroughputscreenfortuberculosisprogression
AT ralphcarvalho highthroughputscreenfortuberculosisprogression
AT jandesonneville highthroughputscreenfortuberculosisprogression
AT oliverwstockhammer highthroughputscreenfortuberculosisprogression
AT nigeldlsavage highthroughputscreenfortuberculosisprogression
AT wouterjveneman highthroughputscreenfortuberculosisprogression
AT tomhmottenhoff highthroughputscreenfortuberculosisprogression
AT ronpdirks highthroughputscreenfortuberculosisprogression
AT annemariehmeijer highthroughputscreenfortuberculosisprogression
AT hermanpspaink highthroughputscreenfortuberculosisprogression
_version_ 1718424144341630976